Literature DB >> 17630472

The angiotensin II receptor antagonist candesartan is not effective in reducing portal hypertension in patients with cirrhosis.

Markus H Heim, Ludwig Jacob, Christoph Beglinger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630472     DOI: 10.1159/000104819

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


× No keyword cloud information.
  2 in total

Review 1.  Angiotensin II receptor blockers for the treatment of portal hypertension in patients with liver cirrhosis: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Huijing Yao; Chunqing Zhang
Journal:  Ir J Med Sci       Date:  2018-02-22       Impact factor: 1.568

Review 2.  Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension.

Authors:  Kwang Yong Shim; Young Woo Eom; Moon Young Kim; Seong Hee Kang; Soon Koo Baik
Journal:  Korean J Intern Med       Date:  2018-02-21       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.